{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:53:47Z","timestamp":1785902027507,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["Core Center for iPS Cell Research, Technological Development and The Acceleration Program for Intractable Diseases Research utilizing Disease-specific iPS cells, Research Center Network for Realization of Regenerative Medicine"],"award-info":[{"award-number":["Core Center for iPS Cell Research, Technological Development and The Acceleration Program for Intractable Diseases Research utilizing Disease-specific iPS cells, Research Center Network for Realization of Regenerative Medicine"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>With few curative treatments for kidney diseases, increasing attention has been paid to regenerative medicine as a new therapeutic option. Recent progress in kidney regeneration using human-induced pluripotent stem cells (hiPSCs) is noteworthy. Based on the knowledge of kidney development, the directed differentiation of hiPSCs into two embryonic kidney progenitors, nephron progenitor cells (NPCs) and ureteric bud (UB), has been established, enabling the generation of nephron and collecting duct organoids. Furthermore, human kidney tissues can be generated from these hiPSC-derived progenitors, in which NPC-derived glomeruli and renal tubules and UB-derived collecting ducts are interconnected. The induced kidney tissues are further vascularized when transplanted into immunodeficient mice. In addition to the kidney reconstruction for use in transplantation, it has been demonstrated that cell therapy using hiPSC-derived NPCs ameliorates acute kidney injury (AKI) in mice. Disease modeling and drug discovery research using disease-specific hiPSCs has also been vigorously conducted for intractable kidney disorders, such as autosomal dominant polycystic kidney disease (ADPKD). In an attempt to address the complications associated with kidney diseases, hiPSC-derived erythropoietin (EPO)-producing cells were successfully generated to discover drugs and develop cell therapy for renal anemia. This review summarizes the current status and future perspectives of developmental biology of kidney and iPSC technology-based regenerative medicine for kidney diseases.<\/jats:p>","DOI":"10.1007\/s10157-021-02030-x","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T11:03:54Z","timestamp":1614769434000},"page":"574-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["iPSC technology-based regenerative medicine for kidney diseases"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7238-2763","authenticated-orcid":false,"given":"Kenji","family":"Osafune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"issue":"10225","key":"2030_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3.","journal-title":"Lancet"},{"issue":"1","key":"2030_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00039.2017","volume":"99","author":"P Karagiannis","year":"2019","unstructured":"Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K. Induced pluripotent stem cells and their use in human models of disease and development. Physiol Rev. 2019;99(1):79\u2013114. https:\/\/doi.org\/10.1152\/physrev.00039.2017.","journal-title":"Physiol Rev"},{"key":"2030_CR3","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511565083","volume-title":"Organogenesis of the kidney","author":"L Saxen","year":"1987","unstructured":"Saxen L. Organogenesis of the kidney. Cambridge: Cambridge University Press; 1987."},{"issue":"1","key":"2030_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1242\/dev.02174","volume":"133","author":"K Osafune","year":"2006","unstructured":"Osafune K, Takasato M, Kispert A, Asashima M, Nishinakamura R. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development. 2006;133(1):151\u201361. https:\/\/doi.org\/10.1242\/dev.02174.","journal-title":"Development"},{"issue":"2","key":"2030_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.stem.2008.05.020","volume":"3","author":"A Kobayashi","year":"2008","unstructured":"Kobayashi A, Valerius MT, Mugford JW, Carroll TJ, Self M, Oliver G, McMahon AP. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. 2008;3(2):169\u201381. https:\/\/doi.org\/10.1016\/j.stem.2008.05.020.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2030_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.stem.2013.11.010","volume":"14","author":"A Taguchi","year":"2014","unstructured":"Taguchi A, Kaku Y, Ohmori T, Sharmin S, Ogawa M, Sasaki H, Nishinakamura R. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell. 2014;14(1):53\u201367. https:\/\/doi.org\/10.1016\/j.stem.2013.11.010.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2030_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ydbio.2008.09.010","volume":"324","author":"JW Mugford","year":"2008","unstructured":"Mugford JW, Sipil\u00e4 P, McMahon JA, McMahon AP. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol. 2008;324(1):88\u201398. https:\/\/doi.org\/10.1016\/j.ydbio.2008.09.010.","journal-title":"Dev Biol"},{"key":"2030_CR8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/ncomms2378","volume":"4","author":"S Mae","year":"2013","unstructured":"Mae S, Shono A, Shiota F, Yasuno T, Kajiwara M, Gotoda-Nishimura N, Arai S, Sato-Otubo A, Toyoda T, Takahashi K, Nakayama N, Cowan CA, Aoi T, Ogawa S, McMahon AP, Yamanaka S, Osafune K. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotentstemcells. Nat Commun. 2013;4:1367. https:\/\/doi.org\/10.1038\/ncomms2378.","journal-title":"Nat Commun"},{"issue":"1","key":"2030_CR9","doi-asserted-by":"publisher","first-page":"e84881","DOI":"10.1371\/journal.pone.0084881","volume":"9","author":"T Araoka","year":"2014","unstructured":"Araoka T, Mae S, Kurose Y, Uesugi M, Ohta A, Yamanaka S, Osafune K. Efficient and rapid induction of human iPSCs\/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods. PLoS ONE. 2014;9(1):e84881. https:\/\/doi.org\/10.1371\/journal.pone.0084881.","journal-title":"PLoS ONE"},{"issue":"7574","key":"2030_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","volume":"526","author":"M Takasato","year":"2015","unstructured":"Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C, Parton RG, Wolvetang EJ, Roost MS, de Sousa C, Lopes SM, Little MH. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015;526(7574):564\u20138. https:\/\/doi.org\/10.1038\/nature15695.","journal-title":"Nature"},{"issue":"11","key":"2030_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nbt.3392","volume":"33","author":"R Morizane","year":"2015","unstructured":"Morizane R, Lam AQ, Freedman BS, Kishi S, Valeius MT, Bonventre JV. Nephron organoids derived from human pluripotent stem cells model\u00a0kidney\u00a0development and injury. Nat Biotechnol. 2015;33(11):1193\u2013200. https:\/\/doi.org\/10.1038\/nbt.3392.","journal-title":"Nat Biotechnol."},{"issue":"1","key":"2030_CR12","doi-asserted-by":"publisher","first-page":"107476","DOI":"10.1016\/j.celrep.2020.03.040","volume":"31","author":"H Tsujimoto","year":"2020","unstructured":"Tsujimoto H, Kasahara T, Sueta S, Araoka T, Sakamoto S, Okada C, Mae SI, Nakajima T, Okamoto N, Taura D, Nasu M, Shimizu T, Ryosaka M, Li Z, Sone M, Ikeya M, Watanabe A, Osafune K. A modular differentiation system maps multiple human kidney lineage from pluripotent stem cells. Cell Rep. 2020;31(1):107476. https:\/\/doi.org\/10.1016\/j.celrep.2020.03.040.","journal-title":"Cell Rep"},{"issue":"6","key":"2030_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.stem.2017.10.011","volume":"21","author":"A Taguchi","year":"2017","unstructured":"Taguchi A, Nishinakamura R. Higher-order kidney organogenesis from pluripotent stem cells. Cell Stem Cell. 2017;21(6):730-46.e6. https:\/\/doi.org\/10.1016\/j.stem.2017.10.011.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2030_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.bbrc.2017.11.105","volume":"495","author":"SI Mae","year":"2018","unstructured":"Mae SI, Ryosaka M, Toyoda T, Matsuse K, Oshima Y, Tsujimoto H, Okumura S, Shibasaki A, Osafune K. Generation of branching ureteric bud tissues from human pluripotent stem cells. Biochem Biophys Res Commun. 2018;495(1):954\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2017.11.105.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2030_CR15","doi-asserted-by":"publisher","first-page":"107963","DOI":"10.1016\/j.celrep.2020.107963","volume":"32","author":"SI Mae","year":"2020","unstructured":"Mae SI, Ryosaka M, Sakamoto S, Matsuse K, Nozaki A, Igami M, Kabai R, Watanabe A, Osafune K. Expansion of human iPSC-derived ureteric bud organoids with repeated branching potential. Cell Rep. 2020;32(4):107963. https:\/\/doi.org\/10.1016\/j.celrep.2020.107963.","journal-title":"Cell Rep"},{"issue":"2","key":"2030_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.devcel.2015.06.021","volume":"34","author":"AC Brown","year":"2015","unstructured":"Brown AC, Muthukrishnan SD, Oxburgh L. A synthetic niche for nephron progenitor cells. Dev Cell. 2015;34(2):229\u201341. https:\/\/doi.org\/10.1016\/j.devcel.2015.06.021.","journal-title":"Dev Cell"},{"issue":"4","key":"2030_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.celrep.2016.03.076","volume":"15","author":"S Tanigawa","year":"2016","unstructured":"Tanigawa S, Taguchi A, Sharma N, Perantoni AO, Nishinakamura R. Selective in vitro propagation of nephron progenitors derived from embryos and pluripotent stem cells. Cell Rep. 2016;15(4):801\u201313. https:\/\/doi.org\/10.1016\/j.celrep.2016.03.076.","journal-title":"Cell Rep"},{"issue":"4","key":"2030_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.stem.2016.07.016","volume":"19","author":"Z Li","year":"2016","unstructured":"Li Z, Araoka T, Wu J, Liao H, Li M, Lazo M, Zhou B, Sui Y, Wu MZ, Tamura I, Xia Y, Beyret E, Matsusaka T, Pastan I, Rodriguez Esteban C, Guillen I, Guillen P, Campistol JM, Izpisua Belmonte JC. 3D culture supports long-term expansion of mouse and human nephrogenic progenitors. Cell Stem Cell. 2016;19(4):516\u201329. https:\/\/doi.org\/10.1016\/j.stem.2016.07.016.","journal-title":"Cell Stem Cell"},{"key":"2030_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.02.130","author":"H Tsujimoto","year":"2020","unstructured":"Tsujimoto H, Araoka T, Nishi Y, Ohta A, Nakahata T, Osafune K. Small molecule TCS21311 can replace BMP7 and facilitate cell proliferation in in vitro expansion culture of nephron progenitor cells. Biochem Biophys Res Commun. 2020. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.130 (in press).","journal-title":"Biochem Biophys Res Commun"},{"key":"2030_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1440-169X.1993.00123.x","volume":"35","author":"N Moriya","year":"1993","unstructured":"Moriya N, Uchiyama H, Asashima M. Induction of pronephric tubules by activin and retinoic acid in presumptive ectoderm of Xenopus laevis. Dev Growth Differ. 1993;35:123\u20138.","journal-title":"Dev Growth Differ"},{"issue":"24","key":"2030_CR21","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1242\/dev.126.24.5847","volume":"126","author":"HC Brennan","year":"1999","unstructured":"Brennan HC, Nijjar S, Jones EA. The specification and growth factor inducibility of the pronephric glomus in Xenopus laevis. Development. 1999;126(24):5847\u201356.","journal-title":"Development"},{"issue":"2","key":"2030_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1440-169x.2002.00631.x","volume":"44","author":"K Osafune","year":"2002","unstructured":"Osafune K, Nishinakamura R, Komazaki S, Asashima M. In vitro induction of the pronephric duct in Xenopus explants. Dev Growth Differ. 2002;44(2):161\u20137. https:\/\/doi.org\/10.1046\/j.1440-169x.2002.00631.x.","journal-title":"Dev Growth Differ"},{"issue":"1","key":"2030_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41467-019-08394-9","volume":"10","author":"T Goto","year":"2019","unstructured":"Goto T, Hara H, Sanbo M, Masaki H, Sato H, Yamaguchi T, Hochi S, Kobayashi T, Nakauchi H, Hirabayashi M. Generation of pluripotent stem cell-derived mouse kidney in Sall1-targeted anephric rats. Nat Commun. 2019;10(1):451. https:\/\/doi.org\/10.1038\/s41467-019-08394-9.","journal-title":"Nat Commun"},{"issue":"11","key":"2030_CR24","doi-asserted-by":"publisher","first-page":"108130","DOI":"10.1016\/j.celrep.2020.108130","volume":"32","author":"T Fujimoto","year":"2020","unstructured":"Fujimoto T, Yamanaka S, Tajiri S, Takamura T, Saito Y, Matsumoto N, Matsumoto K, Tachibana T, Okano HJ, Yokoo T. Generation of human renal vesicles in mouse organ niche using nephron progenitor cell replacement system. Cell Rep. 2020;32(11):108130. https:\/\/doi.org\/10.1016\/j.celrep.2020.108130.","journal-title":"Cell Rep"},{"issue":"10","key":"2030_CR25","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1681\/ASN.2012111089","volume":"24","author":"BS Freedman","year":"2013","unstructured":"Freedman BS, Lam AQ, Sundsbak JL, Iatrino R, Su X, Koon SJ, Wu M, Daheron L, Harris PC, Zhou J, Bonventre JV. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J Am Soc Nephrol. 2013;24(10):1571\u201386. https:\/\/doi.org\/10.1681\/ASN.2012111089.","journal-title":"J Am Soc Nephrol"},{"key":"2030_CR26","doi-asserted-by":"publisher","first-page":"30013","DOI":"10.1038\/srep30013","volume":"6","author":"T Ameku","year":"2015","unstructured":"Ameku T, Taura D, Sone M, Numata T, Nakamura M, Shiota F, Toyoda T, Matsui S, Araoka T, Yasuno T, Mae SI, Kobayashi H, Kondo N, Kitaoka F, Amano N, Arai S, Ichisaka T, Matsuura N, Inoue S, Yamamoto T, Takahashi K, Asaka I, Yamada Y, Ubara Y, Muso E, Fukatsu A, Watanabe A, Sato Y, Nakahata T, Mori Y, Koizumi A, Nakao K, Yamanaka S, Osafune K. Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models. Sci Rep. 2015;6:30013. https:\/\/doi.org\/10.1038\/srep30013.","journal-title":"Sci Rep"},{"issue":"5","key":"2030_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ajhg.2018.03.014","volume":"102","author":"TA Forbes","year":"2018","unstructured":"Forbes TA, Howden SE, Lawlor K, Phipson B, Maksimovic J, Hale L, Wilson S, Quinlan C, Ho G, Holman K, Bennetts B, Crawford J, Trnka P, Oshlack A, Patel C, Mallett A, Simons C, Little MH. Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype and reveal underlying pathogenetic mechanisms. Am J Hum Genet. 2018;102(5):816\u201331. https:\/\/doi.org\/10.1016\/j.ajhg.2018.03.014.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2030_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.stemcr.2018.08.003","volume":"11","author":"S Tanigawa","year":"2018","unstructured":"Tanigawa S, Islam M, Sharmin S, Naganuma H, Yoshimura Y, Haque F, Era T, Nakazato H, Nakanishi K, Sakuma T, Yamamoto T, Kurihara H, Taguchi A, Nishinakamura R. Organoids from nephrotic disease-derived iPSCs identify impaired NEPHRIN localization and slit diaphragm formation in kidney podocytes. Stem Cell Reports. 2018;11(3):727\u201340. https:\/\/doi.org\/10.1016\/j.stemcr.2018.08.003.","journal-title":"Stem Cell Reports"},{"issue":"3","key":"2030_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.stem.2019.06.009","volume":"25","author":"JH Low","year":"2019","unstructured":"Low JH, Li P, Chew EGY, Zhou B, Suzuki K, Zhang T, Lian MM, Liu M, Aizawa E, Rodriguez Esteban C, Yong KSM, Chen Q, Campistol JM, Fang M, Khor CC, Foo JN, Izpisua Belmonte JC, Xia Y. Generation of human PSC-derived kidney organoids with patterned nephron segments and a de novo vascular network. Cell Stem Cell. 2019;25(3):373\u2013879. https:\/\/doi.org\/10.1016\/j.stem.2019.06.009.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2030_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.stem.2018.04.022","volume":"22","author":"SM Czerniecki","year":"2018","unstructured":"Czerniecki SM, Cruz NM, Harder JL, Menon R, Annis J, Otto EA, Gulieva RE, Islas LV, Kim YK, Tran LM, Martins TJ, Pippin JW, Fu H, Kretzler M, Shankland SJ, Himmelfarb J, Moon RT, Paragas N, Freedman BS. High-throughput screening enhances kidney organoid differentiation from human pluripotent stem cells and enables automated multidimensional phenotyping. Cell Stem Cell. 2018;22(6):929\u201340. https:\/\/doi.org\/10.1016\/j.stem.2018.04.022.","journal-title":"Cell Stem Cell"},{"key":"2030_CR31","first-page":"34","volume":"12","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Mae SI, Araoka T, Okita K, Hotta A, Yamagata K, Osafune K. A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs. Biochem Biophys Res Commun. 2020;12:34\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"409","key":"2030_CR32","doi-asserted-by":"publisher","first-page":"eaaj2300","DOI":"10.1126\/scitranslmed.aaj2300","volume":"9","author":"H Hitomi","year":"2017","unstructured":"Hitomi H, Kasahara T, Katagiri N, Hoshina A, Mae SI, Kotaka M, Toyohara T, Rahman A, Nakano D, Niwa A, Saito MK, Nakahata T, Nishiyama A, Osafune K. Human pluripotent stem cell-derived erythropoietin-producing cells ameliorate renal anemia in mice. Sci Transl Med. 2017;9(409):eaaj2300. https:\/\/doi.org\/10.1126\/scitranslmed.aaj2300.","journal-title":"Sci Transl Med"},{"issue":"9","key":"2030_CR33","doi-asserted-by":"publisher","first-page":"980","DOI":"10.5966\/sctm.2014-0219","volume":"4","author":"T Toyohara","year":"2015","unstructured":"Toyohara T, Mae SI, Sueta SI, Inoue T, Yamagishi Y, Kawamoto T, Kasahara T, Hoshina A, Toyoda T, Tanaka H, Araoka T, Sato-Otsubo A, Takahashi K, Sato Y, Yamaji N, Ogawa S, Yamanaka S, Osafune K. Cell therapy using human induced pluripotent stem cell-derived renal progenitors ameliorates acute kidney injury in mice. Stem Cells Transl Med. 2015;4(9):980\u201392. https:\/\/doi.org\/10.5966\/sctm.2014-0219.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"2030_CR34","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1038\/s41598-018-24714-3","volume":"8","author":"A Hoshina","year":"2018","unstructured":"Hoshina A, Kawamoto T, Sueta SI, Mae SI, Araoka T, Tanaka H, Sato Y, Yamagishi Y, Osafune K. Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers. Sci Rep. 2018;8(1):6375. https:\/\/doi.org\/10.1038\/s41598-018-24714-3.","journal-title":"Sci Rep"},{"key":"2030_CR35","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1038\/srep08826","volume":"5","author":"B Imberti","year":"2015","unstructured":"Imberti B, Tomasoni S, Ciampi O, Pezzotta A, Derosas M, Xinaris C, Rizzo P, Papadimou E, Novelli R, Benigni A, Remuzzi G, Morigi M. Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury. Sci Rep. 2015;5:8826. https:\/\/doi.org\/10.1038\/srep08826.","journal-title":"Sci Rep"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-021-02030-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-021-02030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T05:07:49Z","timestamp":1620450469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-021-02030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2030"],"URL":"https:\/\/doi.org\/10.1007\/s10157-021-02030-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"KO is a founder and member without salary of the scientific advisory boards of iPS Portal, Inc., and a founder and chief scientific advisor of RegeNephro Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments with iPSCs were approved by the institutional ethics committees and conducted according to the guidelines of the institutions and the Declaration of Helsinki. All animal experiments were approved by the institutional animal experiment committees and conducted in accordance with the institutional guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all individuals whose iPSCs were used in the studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}